Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether clonazepam is effective and safe in the treatment of rapid eye movement behavior disorder (RBD) of patients with Parkinson's disease (PD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul National University Hospital
Collaborators
NCT05471960 · REM Sleep Behavior Disorder
NCT05721911 · Parkinson Disease, REM Sleep Behavior Disorder
NCT06441864 · Nightmare, Nightmare Disorder With Associated Other Sleep Disorder, and more
NCT06582121 · Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
NCT07361315 · Sleep Terror, Sleepwalking, and more
Seoul National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions